Gabapentin

Rediff.com » News » Gabapentin

News for Gabapentin

Business

Ranbaxy recalls 7.3 cr Gabapentin tablets

In a setback to pharmaceutical major Ranbaxy Laboratories Ltd, the US drug regulator USFDA has directed the company to recall as many as 7.32 crore (73.2 million) Gabapentin tablets of 600 and 800......

Sun-Ranbaxy merger may spill over to 2015

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region Sun......

Ranbaxy may reduce global sales team

Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third.A majority of the job cuts would be in the US, it is......

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India's top drugmaker agreed to pay a hefty $500 million......

Ranbaxy to pay $500 mn to settle US fraud charges

The country’s biggest drugmaker, Ranbaxy Laboratories on Monday agreed to pay $500 million (around Rs 2,743 crore) to resolve fraud allegations made in a whistle-blower’s lawsuit and......

Rediff News

Gabapentin

News for Gabapentin

Ranbaxy recalls 7.3 cr Gabapentin tablets

Sun-Ranbaxy merger may spill over to 2015

Ranbaxy may reduce global sales team

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy to pay $500 mn to settle US fraud charges

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS